These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31536489)
21. Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains. Cencig S; Coltel N; Truyens C; Carlier Y Int J Antimicrob Agents; 2012 Dec; 40(6):527-32. PubMed ID: 23063742 [TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease. Matsuo AL; Silva LS; Torrecilhas AC; Pascoalino BS; Ramos TC; Rodrigues EG; Schenkman S; Caires AC; Travassos LR Antimicrob Agents Chemother; 2010 Aug; 54(8):3318-25. PubMed ID: 20479201 [TBL] [Abstract][Full Text] [Related]
23. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives. Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965 [TBL] [Abstract][Full Text] [Related]
24. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase. Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582 [TBL] [Abstract][Full Text] [Related]
26. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain. Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559 [TBL] [Abstract][Full Text] [Related]
27. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole. Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216 [TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro auranofin activity against Trypanosoma cruzi: Possible new uses for an old drug. da Silva MT; Silva-Jardim I; Portapilla GB; de Lima GM; Costa FC; Anibal Fde F; Thiemann OH Exp Parasitol; 2016 Jul; 166():189-93. PubMed ID: 26183422 [TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors. Silva JJ; Osakabe AL; Pavanelli WR; Silva JS; Franco DW Br J Pharmacol; 2007 Sep; 152(1):112-21. PubMed ID: 17603548 [TBL] [Abstract][Full Text] [Related]
31. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II). Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788 [TBL] [Abstract][Full Text] [Related]
32. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi. Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605 [TBL] [Abstract][Full Text] [Related]
33. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection. Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145 [TBL] [Abstract][Full Text] [Related]
34. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease. Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982 [TBL] [Abstract][Full Text] [Related]
35. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi. Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830 [TBL] [Abstract][Full Text] [Related]
37. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi. Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153 [TBL] [Abstract][Full Text] [Related]
38. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs. Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285 [TBL] [Abstract][Full Text] [Related]
39. The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice. Miguel DC; Ferraz ML; Alves Rde O; Yokoyama-Yasunaka JK; Torrecilhas AC; Romanha AJ; Uliana SR Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):945-8. PubMed ID: 21120371 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi. Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]